Replies to post #13511 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

If the FDA grants priority review, the PDUFA date should be on or about 3-Feb-2009.

[floblu14]

Tell ya what -

Put Jess, Dew & myself in charge (M--, C----- & Flo) & you get bet your a-- the stock would go through the hen-house roof LOL

Realistically, fair feathered goatees, Read & Okey, this stock is a screaming bargain at 96 half Lincolns!!

Take what Dr. Jess said & X it by two :-)

Still waiting to hear from my contact at Merrimack - no one has ceased to exist from MM-093 - so -------->

[stockdak]

GTCB has anticipated cash to about November-December of this year. There are pending milestones for Atryn HD from LEO and Ovation.

With a cash burn of about $20 million a year GTCB is about $10 million short (6 months) of having enough cash to get to where they would receive milestone payments that would sustain the company going forward.

Ovation Deal possible milestone in 1H 09-2H09:
1.) Atryn FDA approval $4 million ($9 mil - $5 mil in 08).
2.) Initiation of a phase-3 trial in the CABG indication. (some part of $248 million)

From the LEO deal:
$38M for clinical/regulatory milestones in the DIC/sepsis indication (some amount of this could come at the end of PII in 2H 09).
$30M for sales-based milestones (commercial sales are ongoing so these milestones could kick in).